• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis.

作者信息

Ford Mark, Sahbudin Ilfita, Filer Andrew, Steven Neil, Fisher Benjamin A

机构信息

Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Rheumatology Research Group, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.

出版信息

Rheumatology (Oxford). 2018 Dec 1;57(12):2244-2246. doi: 10.1093/rheumatology/key234.

DOI:10.1093/rheumatology/key234
PMID:30107548
Abstract
摘要

相似文献

1
High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1-associated inflammatory arthritis.在使用柳氮磺胺吡啶治疗抗PD-1相关炎性关节炎后，药物过敏反应的比例很高。
Rheumatology (Oxford). 2018 Dec 1;57(12):2244-2246. doi: 10.1093/rheumatology/key234.
2
Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome.
Turk J Gastroenterol. 2009 Dec;20(4):298-9. doi: 10.4318/tjg.2009.0032.
3
Hypersensitivity reaction to sulfasalazine: skin rash, fever, hepatitis and activated lymphocytes.
Clin Exp Rheumatol. 1992 Jul-Aug;10(4):427.
4
Sulfasalazine-Related Hypersensitivity Reactions in Patients With Rheumatic Diseases.风湿性疾病患者中与柳氮磺胺吡啶相关的超敏反应
J Clin Rheumatol. 2017 Mar;23(2):77-79. doi: 10.1097/RHU.0000000000000490.
5
[A case of salazosulfapyridine induced hypersensitivity syndrome].[一例柳氮磺胺吡啶诱发的超敏反应综合征]
Nihon Shokakibyo Gakkai Zasshi. 2005 May;102(5):600-4.
6
Sulphasalazine: a 'new' antirheumatic drug.
Br J Rheumatol. 1984 Feb;23(1):26-34. doi: 10.1093/rheumatology/23.1.26.
7
Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.柳氮磺吡啶超敏反应综合征导致疑似类风湿关节炎出现淋巴瘤样表现。
N Z Med J. 2008 Jun 20;121(1276):102-5.
8
[Sulfasalazine-induced DRESS syndrome associated with Epstein Barr virus reactivation].[柳氮磺胺吡啶诱导的伴爱泼斯坦-巴尔病毒再激活的药物超敏反应综合征]
Therapie. 2013 Sep-Oct;68(5):321-3. doi: 10.2515/therapie/2013049. Epub 2013 Nov 14.
9
Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.柳氮磺胺吡啶肝毒性：缺乏超敏反应。
Ann Rheum Dis. 1986 Nov;45(11):967-8. doi: 10.1136/ard.45.11.967.
10
Giant cell myocarditis in a patient with a spondyloarthropathy after a drug hypersensitivity reaction.巨细胞心肌炎患者在药物过敏反应后出现脊椎关节病。
Can J Cardiol. 2013 Sep;29(9):1138.e7-8. doi: 10.1016/j.cjca.2012.12.011. Epub 2013 Mar 6.

引用本文的文献

1
Immune checkpoint inhibitor-induced inflammatory arthritis.免疫检查点抑制剂诱导的炎性关节炎。
Clin Med (Lond). 2025 Aug 6;25(5):100496. doi: 10.1016/j.clinme.2025.100496.
2
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis.免疫检查点抑制剂相关的类风湿关节炎
Curr Rheumatol Rep. 2024 Nov 26;27(1):3. doi: 10.1007/s11926-024-01173-6.
3
Immune checkpoint blockade lowers the threshold of naïve T-cell priming to drug-associated antigens in a dose-dependent fashion.免疫检查点阻断以剂量依赖的方式降低了幼稚 T 细胞对药物相关抗原的初始激活阈值。
Toxicol Sci. 2024 Nov 1;202(1):13-18. doi: 10.1093/toxsci/kfae118.
4
Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor Therapies.免疫药物-药物相互作用影响免疫检查点抑制剂治疗的疗效和安全性。
Chem Res Toxicol. 2024 Jul 15;37(7):1086-1103. doi: 10.1021/acs.chemrestox.4c00067. Epub 2024 Jun 24.
5
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.免疫检查点抑制剂相关炎性关节炎：当前的治疗方法。
Rheum Dis Clin North Am. 2024 May;50(2):269-279. doi: 10.1016/j.rdc.2024.02.002. Epub 2024 Mar 8.
6
Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review.药物超敏反应伴嗜酸性粒细胞增多和全身症状的发病机制及治疗意义的研究进展：最新综述
Front Med (Lausanne). 2023 Jun 29;10:1187937. doi: 10.3389/fmed.2023.1187937. eCollection 2023.
7
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions.严重皮肤不良反应的免疫病理学和基因组学研究进展。
J Allergy Clin Immunol. 2023 Feb;151(2):289-300.e4. doi: 10.1016/j.jaci.2022.12.005.
8
Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study.使用 bDMARD 或 tsDMARD 治疗检查点抑制剂治疗下的炎症性关节炎：一项观察性研究。
RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002612.
9
Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature.帕博利珠单抗诱发晚期肺鳞状细胞癌患者发生史蒂文斯-约翰逊综合征：一例报告并文献复习
World J Clin Cases. 2022 Jun 26;10(18):6110-6118. doi: 10.12998/wjcc.v10.i18.6110.
10
Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity.遗传的实际应用：免疫基因组学的新概念可用于预测、预防和诊断药物过敏。
J Allergy Clin Immunol Pract. 2022 Jul;10(7):1689-1700. doi: 10.1016/j.jaip.2022.04.027. Epub 2022 May 6.